Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,790,506
+$147,610 QoQ
Shares Held
12,200
-1.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisors Asset Management, Inc. holds $38,396,219 across 40 Biotechnology names. ASND ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,300 | $10,850,922 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
177,703 | $4,399,926 | |
| 3 | ASND |
Ascendis Pharma A/S
This page
|
12,200 | $2,790,506 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,085 | $2,383,594 | |
| 5 | INCY |
Incyte Corp
|
21,594 | $2,032,427 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
79,116 | $1,863,972 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
18,718 | $1,627,904 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
6,948 | $1,387,168 |
All Filings in ASND
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,790,506 | 12,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,642,896 | 12,394 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,109,175 | 10,609 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,807,467 | 10,472 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,432,353 | 9,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,134,538 | 8,241 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $708,028 | 4,742 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $524,790 | 3,848 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $516,799 | 5,519 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $501,317 | 5,617 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $631,204 | 5,887 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $750,000 | 6,141 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,633,160 | 15,816 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,556,987 | 16,749 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,968,244 | 16,771 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,186,247 | 16,251 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,360,247 | 14,808 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,975,881 | 15,020 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,775,966 | 13,780 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,419,798 | 8,513 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $709,409 | 4,597 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $597,072 | 4,037 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $151,347 | 1,344 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||